These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 11023050

  • 1. Effect of antiandrogen, chlormadinone acetate (CMA), in canine spontaneous benign prostatic hyperplasia (BPH).
    Murakoshi M, Ikada R, Tagawa M, Nakayama T.
    Tokai J Exp Clin Med; 2000 Apr; 25(1):11-4. PubMed ID: 11023050
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunohistochemical studies in canine prostatic hyperplasia--effect of antiandrogen.
    Murakoshi M, Ikeda R, Tagawa M, Nakayama T.
    Tokai J Exp Clin Med; 1999 Jun; 24(2):77-83. PubMed ID: 10641996
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory influence of a new steroidal anti-androgen, TZP-4238, on prostatic hyperplasia in the beagle dog.
    Murakoshi M, Inada R, Tagawa M, Makino M, Suzuki M, Mieda M, Honma S, Takezawa Y, Yamanaka H.
    Acta Pathol Jpn; 1992 Mar; 42(3):151-7. PubMed ID: 1373927
    [Abstract] [Full Text] [Related]

  • 7. Ultrastructural study in canine prostatic hyperplasia--effect of antiandrogen.
    Murakoshi M, Masuda S, Ikeda R, Tagawa M, Nakayama T, Honma S, Mieda M.
    Tokai J Exp Clin Med; 1998 Nov; 23(5):245-8. PubMed ID: 10418729
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia.
    Ito K, Fukabori Y, Shibata Y, Suzuki K, Mieda M, Gotanda K, Honma S, Yamanaka H.
    Eur J Endocrinol; 2000 Oct; 143(4):543-54. PubMed ID: 11022202
    [Abstract] [Full Text] [Related]

  • 12. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
    Shibata Y, Fukabori Y, Ito K, Suzuki K, Yamanaka H.
    J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
    [Abstract] [Full Text] [Related]

  • 13. Chlormadinone acetate pellet implantation plus short-term oral administration in dogs with benign prostatic hypertrophy.
    Kawakami E, Shimizu M, Orima H, Fujita M, Hori T, Tsutsui T.
    Int J Androl; 1998 Apr; 21(2):67-73. PubMed ID: 9675615
    [Abstract] [Full Text] [Related]

  • 14. [Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography].
    Suzuki K, Ichinose Y, Hashimoto K, Matsumoto K, Suzuki T, Imai K, Yamanaka H.
    Hinyokika Kiyo; 1990 May; 36(5):557-60. PubMed ID: 1698012
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of oral administration of chlormadinone acetate on canine prostatic hypertrophy.
    Kawakami E, Tsutsui T, Shimizu M, Orima H, Makanae Y, Yajima K, Ogasa A.
    J Vet Med Sci; 1993 Aug; 55(4):631-5. PubMed ID: 7691191
    [Abstract] [Full Text] [Related]

  • 17. Effect of anti-androgen (TZP-4238) on steroid-induced canine prostatic hyperplasia. Light and electron microscopic investigations.
    Murakoshi M, Inada R, Makino M, Suzuki M, Mieda M, Honma S, Yamanaka H.
    Acta Pathol Jpn; 1990 Dec; 40(12):871-9. PubMed ID: 1710865
    [Abstract] [Full Text] [Related]

  • 18. Effects of the new steroidal antiandrogen TZP-4238 on hormone-induced canine prostatic hyperplasia.
    Takezawa Y, Fukabori Y, Yamanaka H, Mieda M, Honma S, Kushitani M, Hamataki N.
    Prostate; 1992 Dec; 21(4):315-29. PubMed ID: 1281324
    [Abstract] [Full Text] [Related]

  • 19. [Rebound of prostate specific antigen after discontinuation of antiandrogen therapy for benign prostatic hyperplasia].
    Noguchi K, Uemura H, Takeda M, Sekiguchi Y, Ogawa K, Hosaka M.
    Hinyokika Kiyo; 2000 Sep; 46(9):605-7. PubMed ID: 11107528
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.